Key result
Genetically higher diastolic blood pressure linearly increased myocardial infarction risk with no evidence of a J-shaped relationship.
Why the study?
Recent clinical guidelines support intensive blood pressure treatment targets, yet observational data suggest that excessive DBP lowering might increase MI risk via a J- or U-shaped relationship.
Does genetically predicted lower diastolic blood pressure increase or decrease the risk of cardiovascular disease events and myocardial infarction in a cohort of 47,407 participants?
Cohort (n=47,407)
Yes
Does genetically predicted lower diastolic blood pressure increase or decrease the risk of cardiovascular disease events and myocardial infarction in a cohort of 47,407 participants?
Linear and nonlinear Mendelian randomization analyses demonstrate that myocardial infarction risk decreases consistently with lower diastolic blood pressure, refuting observational evidence of a J-shaped curve even at low baseline DBP levels.
Answers are grounded in this paper and cite their sources.
Intensive DBP lowering appears safe for MI risk; challenges observational J-curve and supports linear benefit via MR.
Background: Recent clinical guidelines support intensive blood pressure treatment targets. However, observational data suggest that excessive diastolic blood pressure (DBP) lowering might increase the risk of myocardial infarction (MI), reflecting a J- or U-shaped relationship. Methods: We analyzed 47 407 participants from 5 cohorts (median age, 60 years). First, to corroborate previous observational analyses, we used traditional statistical methods to test the shape of association between DBP and cardiovascular disease (CVD). Second, we created polygenic risk scores of DBP and systolic blood pressure and generated linear Mendelian randomization (MR) estimates for the effect of DBP on CVD. Third, using novel nonlinear MR approaches, we evaluated for nonlinearity in the genetic relationship between DBP and CVD events. Comprehensive MR interrogation of DBP required us to also model systolic blood pressure, given that the 2 are strongly correlated. Results: Traditional observational analysis of our cohorts suggested a J-shaped association between DBP and MI. By contrast, linear MR analyses demonstrated an adverse effect of increasing DBP increments on CVD outcomes, including MI (MI hazard ratio, 1.07 per unit mm Hg increase in DBP; P <0.001). Furthermore, nonlinear MR analyses found no evidence for a J-shaped relationship; instead confirming that MI risk decreases consistently per unit decrease in DBP, even among individuals with low values of baseline DBP. Conclusions: In this analysis of the genetic effect of DBP, we found no evidence for a nonlinear J- or U-shaped relationship between DBP and adverse CVD outcomes; including MI.
No takes yet. Share an insight, caveat, or question.
Arvanitis et al. (2020) conducted a cohort in Cardiovascular disease and myocardial infarction (n=47,407). Genetically predicted diastolic blood pressure (per unit mm Hg increase) vs. Lower diastolic blood pressure was evaluated on Cardiovascular disease outcomes, including myocardial infarction (MI) (HR 1.07, p=<0.001). Genetically higher diastolic blood pressure linearly increased myocardial infarction risk with no evidence of a J-shaped relationship.
Synapse has enriched 10 related papers. Consider them for comparative context: